But the really interesting question is why BPC-157 seems capable of accelerating healing across so many completely different tissues and organs
Peptide Therapy GHK-Cu: COPPER PEPTIDE THERAPY A naturally occurring peptide that declines with age
They can impact peptide effectiveness
Another complication: MIC B12 isnt standardized, so results (and risks) can vary by formulation and preparation
CagriSema treatment resulted in substantially greater and clinically meaningful weight loss (-20.4%) than semaglutide alone (-14.9%), cagrilintide alone (-11.5%), or placebo (-3.0%), a finding consistent with at least partial additivity, although the study design does not permit a formal assessment of additive or synergistic effects
Injectable-grade GHK-Cu sold in the research peptide market is explicitly labelled "not for human consumption," which isn't a legal formality, it reflects that this supply chain sits outside pharmacopeial oversight